2015
DOI: 10.1021/jacs.5b06110
|View full text |Cite
|
Sign up to set email alerts
|

New Antibiotic Candidates againstHelicobacter pylori

Abstract: Helicobacter pylori is a Gram-negative bacterium that colonizes the gut of over 50% of the world's population. It is responsible for most peptic ulcers and is an important risk factor for gastric cancer. Antibiotic treatment for H. pylori infections is challenging as drug resistance has developed to antibiotics with traditional mechanisms of action. H. pylori uses an unusual pathway for menaquinone biosynthesis with 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (MTAN) catalyzing an essential step.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
95
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 40 publications
(97 citation statements)
references
References 35 publications
2
95
0
Order By: Relevance
“…8,52 Derivatives of two distinct chemical scaffolds gave 14 compounds with IC 90 values at or below 16 ng/mL for H. pylori growth (Figure 10). Blocking growth of the bacteria requires entry into the cell and inhibition of the H. pylori MTAN.…”
Section: Bacterial Menaquinone Synthesis: the Futalosine Pathwaymentioning
confidence: 99%
See 2 more Smart Citations
“…8,52 Derivatives of two distinct chemical scaffolds gave 14 compounds with IC 90 values at or below 16 ng/mL for H. pylori growth (Figure 10). Blocking growth of the bacteria requires entry into the cell and inhibition of the H. pylori MTAN.…”
Section: Bacterial Menaquinone Synthesis: the Futalosine Pathwaymentioning
confidence: 99%
“…5,6 BT-DADMe-Immucillin-A and related analogues are powerful antibiotics for Helicobacter pylori . 7,8 …”
Section: Figurementioning
confidence: 99%
See 1 more Smart Citation
“…One such target in this pathway is a homodimeric enzyme, H. pylori 5′-methylthioadenosine nucleosidase (HpMTAN), that hydrolyzes the N-ribosidic bond of 6-amino-6-deoxyfutalosine (Fig. 1A) (2)(3)(4). Additionally, HpMTAN hydrolyzes the N-ribosidic bond of other adenosine-containing metabolites such as S-adenosylhomocysteine (SAH) ( Table S1) and 5′-deoxyadenosine (5-7) and therefore functions as a central metabolic hub.…”
mentioning
confidence: 99%
“…17,18 Transition-state analogue inhibitors of H. pylori MTAN are more powerful antibiotics against this organism than any of the antibiotics currently approved for H. pylori infections. 19,20 …”
mentioning
confidence: 99%